Business Context and Reporting Period
Company: NeOnc Technologies Holdings, Inc. (NTHI)
Filing Type: Form 8-K (Current Report)
Date of Report: February 27, 2026
Reporting Period: Single event date (February 27, 2026)
Business Context: The Company is an emerging growth company incorporated in Delaware, focused on clinical development. This filing serves as a Regulation FD disclosure regarding an upcoming investor conference call.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This Form 8-K is a current report regarding a corporate event and does not contain financial statements or performance metrics.
Material Changes
No material financial changes versus a prior comparable period are reported in this document. The filing announces a scheduled corporate event rather than a change in financial condition or operational results.
Guidance, Outlook, and Management Commentary
- Upcoming Event: The Company will host an investor conference call and webcast on Wednesday, March 4, 2026, at 9:00 a.m. Eastern Time.
- Subject Matter: The call will present initial data from the Phase 1 dose-escalation portion of the NEO212-01 Phase 1/2 clinical trial.
- Disclosure Status: The information in Item 7.01 and the accompanying press release (Exhibit 99.1) is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act, nor is it incorporated by reference into other filings except as expressly set forth.
Investor Verification Checklist
- Verify the date and time of the investor conference call (March 4, 2026, 9:00 a.m. ET).
- Review the full text of the press release furnished as Exhibit 99.1 for specific details on the NEO212-01 trial data.
- Confirm the trading symbol (NTHI) and exchange (The Nasdaq Stock Market LLC) for the Common Stock.
- Note that this filing does not contain audited financial data; refer to the most recent 10-K or 10-Q for financial health metrics.